Light Mode
$25.36 ↑ +0.00 (+0.00%) Trading Up from the previous close of $25.36, $0.05 below the day’s high of $25.41
-7.03 (-21.70%) / 6M
Momentum, market sentiment, and recent alerts
VKTX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -27.4%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.